Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 106,390 | 107,844 | 85,247 | 134,875 | 121,847 |
| Receivables | 854,392 | 529,760 | 544,205 | 575,474 | 441,214 |
| Inventories | 523,979 | 393,441 | 365,318 | 330,201 | 399,238 |
| Other current assets | 0 | 94 | 0 | 0 | 0 |
| TOTAL | $1,484,762 | $1,245,125 | $1,194,875 | $1,110,911 | $1,023,515 |
| Non-Current Assets | |||||
| PPE Net | 166,688 | 149,846 | 23,669 | 27,153 | 57,484 |
| Investments And Advances | 120,289 | 15,704 | 13,391 | 11,991 | 23,203 |
| Intangibles | 5,015,976 | 5,578,657 | 5,669,316 | 3,965,288 | 4,480,238 |
| Other Non-Current Assets | 103,937 | 147,670 | 79,589 | 86,912 | 89,432 |
| TOTAL | $5,406,891 | $5,891,877 | $5,785,965 | $4,091,344 | $4,650,357 |
| Total Assets | $6,891,755 | $7,137,002 | $6,980,746 | $5,202,354 | $5,673,873 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 607,272 | 371,400 | 831,066 | 574,384 | 206,149 |
| Accounts payable and accrued liabilities | 126,217 | 89,302 | 96,563 | 124,073 | 65,063 |
| Accrued Expenses | N/A | 536,760 | 494,886 | 520,572 | 579,152 |
| Other current liabilities | 897,009 | 111,344 | 357,208 | 237,741 | 153,212 |
| TOTAL | $1,642,252 | $1,191,960 | $1,800,658 | $1,472,329 | $1,021,533 |
| Non-Current Liabilities | |||||
| Long Term Debt | 529,396 | 1,173,702 | 1,070,871 | 294,426 | 1,023,398 |
| Other Non-Current Liabilities | 419,531 | 325,802 | 285,635 | 430,589 | 503,129 |
| TOTAL | $1,394,212 | $2,132,946 | $1,986,430 | $1,101,298 | $1,946,870 |
| Total Liabilities | $3,036,464 | $3,325,095 | $3,787,088 | $2,573,727 | $2,968,403 |
| Shareholders' Equity | |||||
| Common Shares | 20,031 | 18,447 | 18,294 | 16,847 | 19,705 |
| Retained earnings | 2,289,484 | 2,074,010 | 1,702,587 | 1,565,086 | 1,533,873 |
| Other shareholders' equity | -262,755 | 93,654 | -88,077 | 34,784 | -7,695 |
| TOTAL | $3,855,291 | $3,811,907 | $3,193,658 | $2,628,627 | $2,705,470 |
| Total Liabilities And Equity | $6,891,755 | $7,137,002 | $6,980,746 | $5,202,354 | $5,673,873 |